PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 175 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$433,000
+3.6%
7,038
-1.6%
0.00%0.0%
Q4 2017$418,000
+0.7%
7,155
+0.2%
0.00%0.0%
Q3 2017$415,000
-76.8%
7,144
-51.6%
0.00%
-60.0%
Q2 2017$1,788,000
+146.3%
14,770
+130.1%
0.01%
+25.0%
Q1 2017$726,000
-7.9%
6,4200.0%0.00%0.0%
Q4 2016$788,000
-25.4%
6,4200.0%0.00%
-33.3%
Q3 2016$1,057,000
+30.7%
6,420
+13.2%
0.01%
+20.0%
Q2 2016$809,000
+6.0%
5,671
-4.5%
0.01%0.0%
Q1 2016$763,000
+1.5%
5,937
+17.9%
0.01%0.0%
Q4 2015$752,000
-15.4%
5,037
-6.1%
0.01%
-16.7%
Q3 2015$889,000
-73.7%
5,362
-61.8%
0.01%
-68.4%
Q2 2015$3,386,000
-14.4%
14,0270.0%0.02%
-17.4%
Q1 2015$3,956,000
+115.4%
14,027
+19.1%
0.02%
+109.1%
Q4 2014$1,837,000
+37.8%
11,777
+109.1%
0.01%
+37.5%
Q3 2014$1,333,000
-11.4%
5,633
-11.4%
0.01%0.0%
Q2 2014$1,505,0006,3600.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders